IDSA Releases Guidance On Treatment Of Antimicrobial-Resistant Infections
Developed by a panel of six infectious diseases specialists with clinical and research expertise in the treatment of AMR bacterial infections, this first-in-a-series guidance addresses three groups of AMR Gram-negative bacteria that pose particular therapeutic challenges and have been designated as urgent or serious threats by CDC:
- Extended-spectrum β-lactamase producing Enterobacterales (ESBL-E)
- Carbapenem-resistant Enterobacterales (CRE)
- Difficult-to-treat resistance (DTR)-Pseudomonas aeruginosa
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!